FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113099825> ?p ?o ?g. }

• W2113099825 endingPage "490" @default.
• W2113099825 startingPage "481" @default.
• W2113099825 abstract "Tumor necrosis factor (TNF)-alpha plays a central role in the pathogenesis of rheumatoid arthritis (RA) and is instrumental in causing joint destruction, the clinical hallmark of the disease. Recognizing this, in recent years biological therapies have been developed that work by blocking the damaging effects of TNF-alpha on synovium and cartilage. Three such agents are currently approved for treatment in RA - etanercept, infliximab and adalimumab. Although these agents are very effective in slowing the clinical and structural progression in RA, they are expensive, totaling several thousand dollars in yearly costs. Furthermore, only about 60% of patients respond effectively to these agents. As RA is a chronic disease, with most patients expected to remain on these therapies for life, ways to prospectively identify patients most likely to benefit from these agents are being explored. Pharmacogenomic approaches form the basis of most such screening methods. Polymorphisms in genes encoding TNF-alpha, TNF-alpha receptors, other cytokines, and the major histocompatibility complex region, and their ability to predict response to anti-TNF therapies, have been the focus of many recent studies. The results from such studies are mixed, with some suggesting that single nucleotide polymorphisms (SNPs) in these genes are significant, while others conclude that such SNPs are irrelevant in predicting response. Such conflicting results are likely to be due to a variety of factors, as discussed in this article. Whether pharmacogenomics will allow prediction of anti-TNF therapy efficacy in RA remains a question with no clear answers to date. Large, prospective, multicenter studies with the examination of not just individual SNPs, but also multi-SNP haplotypes, are needed to address this question in the future." @default.
• W2113099825 created "2016-06-24" @default.
• W2113099825 creator A5065315851 @default.
• W2113099825 date "2005-07-01" @default.
• W2113099825 modified "2023-10-18" @default.
• W2113099825 title "Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis" @default.
• W2113099825 cites W1497954397 @default.
• W2113099825 cites W1966922291 @default.
• W2113099825 cites W1971551795 @default.
• W2113099825 cites W1974003531 @default.
• W2113099825 cites W1977927757 @default.
• W2113099825 cites W1982364998 @default.
• W2113099825 cites W1992702174 @default.
• W2113099825 cites W1996472975 @default.
• W2113099825 cites W2001046375 @default.
• W2113099825 cites W2001660220 @default.
• W2113099825 cites W2002295754 @default.
• W2113099825 cites W2015865604 @default.
• W2113099825 cites W2017060960 @default.
• W2113099825 cites W2017720269 @default.
• W2113099825 cites W2023102754 @default.
• W2113099825 cites W2024913341 @default.
• W2113099825 cites W2031504111 @default.
• W2113099825 cites W2034464736 @default.
• W2113099825 cites W2038697192 @default.
• W2113099825 cites W2039186692 @default.
• W2113099825 cites W2043415837 @default.
• W2113099825 cites W2046628605 @default.
• W2113099825 cites W2048046009 @default.
• W2113099825 cites W2052119995 @default.
• W2113099825 cites W2066657532 @default.
• W2113099825 cites W2072738451 @default.
• W2113099825 cites W2086255604 @default.
• W2113099825 cites W2086721113 @default.
• W2113099825 cites W2091852263 @default.
• W2113099825 cites W2097315308 @default.
• W2113099825 cites W2099671460 @default.
• W2113099825 cites W2102225613 @default.
• W2113099825 cites W2122265491 @default.
• W2113099825 cites W2122833930 @default.
• W2113099825 cites W2165886134 @default.
• W2113099825 cites W2312197522 @default.
• W2113099825 cites W2314052274 @default.
• W2113099825 cites W2319957449 @default.
• W2113099825 cites W2332739634 @default.
• W2113099825 cites W2340084730 @default.
• W2113099825 doi "https://doi.org/10.2217/14622416.6.5.481" @default.
• W2113099825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16013998" @default.
• W2113099825 hasPublicationYear "2005" @default.
• W2113099825 type Work @default.
• W2113099825 sameAs 2113099825 @default.
• W2113099825 citedByCount "46" @default.
• W2113099825 countsByYear W21130998252012 @default.
• W2113099825 countsByYear W21130998252013 @default.
• W2113099825 countsByYear W21130998252014 @default.
• W2113099825 countsByYear W21130998252015 @default.
• W2113099825 countsByYear W21130998252017 @default.
• W2113099825 countsByYear W21130998252019 @default.
• W2113099825 countsByYear W21130998252021 @default.
• W2113099825 crossrefType "journal-article" @default.
• W2113099825 hasAuthorship W2113099825A5065315851 @default.
• W2113099825 hasConcept C104317684 @default.
• W2113099825 hasConcept C126322002 @default.
• W2113099825 hasConcept C135763542 @default.
• W2113099825 hasConcept C143998085 @default.
• W2113099825 hasConcept C153209595 @default.
• W2113099825 hasConcept C170734499 @default.
• W2113099825 hasConcept C17991360 @default.
• W2113099825 hasConcept C203014093 @default.
• W2113099825 hasConcept C2777077863 @default.
• W2113099825 hasConcept C2777138892 @default.
• W2113099825 hasConcept C2777226972 @default.
• W2113099825 hasConcept C2777575956 @default.
• W2113099825 hasConcept C2779134260 @default.
• W2113099825 hasConcept C2780132546 @default.
• W2113099825 hasConcept C54355233 @default.
• W2113099825 hasConcept C55775858 @default.
• W2113099825 hasConcept C60644358 @default.
• W2113099825 hasConcept C71924100 @default.
• W2113099825 hasConcept C86803240 @default.
• W2113099825 hasConcept C98274493 @default.
• W2113099825 hasConceptScore W2113099825C104317684 @default.
• W2113099825 hasConceptScore W2113099825C126322002 @default.
• W2113099825 hasConceptScore W2113099825C135763542 @default.
• W2113099825 hasConceptScore W2113099825C143998085 @default.
• W2113099825 hasConceptScore W2113099825C153209595 @default.
• W2113099825 hasConceptScore W2113099825C170734499 @default.
• W2113099825 hasConceptScore W2113099825C17991360 @default.
• W2113099825 hasConceptScore W2113099825C203014093 @default.
• W2113099825 hasConceptScore W2113099825C2777077863 @default.
• W2113099825 hasConceptScore W2113099825C2777138892 @default.
• W2113099825 hasConceptScore W2113099825C2777226972 @default.
• W2113099825 hasConceptScore W2113099825C2777575956 @default.
• W2113099825 hasConceptScore W2113099825C2779134260 @default.
• W2113099825 hasConceptScore W2113099825C2780132546 @default.
• W2113099825 hasConceptScore W2113099825C54355233 @default.
• W2113099825 hasConceptScore W2113099825C55775858 @default.
• W2113099825 hasConceptScore W2113099825C60644358 @default.

• next